Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
暂无分享,去创建一个
Chaim A. Schramm | Cinque S. Soto | J. Mullikin | J. Mascola | J. Binley | John P. Moore | I. Wilson | Zhenhai Zhang | S. Karim | C. Soto | I. Georgiev | L. Morris | R. Bailer | N. Doria-Rose | M. Louder | K. Mckee | L. Shapiro | P. Kwong | Helen J Kim | G. Georgiou | A. Ward | S. O'dell | Yongping Yang | J. Gorman | P. Moore | J. Bhiman | B. Dekosky | Michael J. Ernandes | M. Pancera | Ryan P. Staupe | H. Altae-Tran | E. Crooks | A. Cupo | A. Druz | N. Garrett | K. H. Hoi | R. Kong | N. Longo | M. Nonyane | Ryan S Roark | R. Rudicell | S. Schmidt | D. Sheward | C. K. Wibmer | R. Sanders | C. Williamson | Helen J. Kim | Rebecca S. Rudicell | Ryan S. Roark | Rui Kong | S. O’dell | Han Altae-Tran
[1] E. Kabat,et al. Sequences of proteins of immunological interest , 1991 .
[2] M van Heel,et al. A new generation of the IMAGIC image processing system. , 1996, Journal of structural biology.
[3] H Hui,et al. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin , 1996, Journal of virology.
[4] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[5] M. Steel,et al. General time-reversible distances with unequal rates across sites: mixing gamma and inverse Gaussian distributions with invariant sites. , 1997, Molecular phylogenetics and evolution.
[6] W Chiu,et al. EMAN: semiautomated software for high-resolution single-particle reconstructions. , 1999, Journal of structural biology.
[7] Adam Godzik,et al. Clustering of highly homologous sequences to reduce the size of large protein databases , 2001, Bioinform..
[8] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[9] M. Nussenzweig,et al. Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.
[10] V. Giudicelli,et al. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. , 2003, Developmental and comparative immunology.
[11] Martin A. Nowak,et al. Antibody neutralization and escape by HIV-1 , 2003, Nature.
[12] D. Richman,et al. Rapid evolution of the neutralizing antibody response to HIV type 1 infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[13] David C. Richardson,et al. MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes , 2004, Nucleic Acids Res..
[14] G. Crooks,et al. WebLogo: a sequence logo generator. , 2004, Genome research.
[15] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[16] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[17] P. Lipsky,et al. Characterization of the Human Ig Heavy Chain Antigen Binding Complementarity Determining Region 3 Using a Newly Developed Software Algorithm, JOINSOLVER , 2004, The Journal of Immunology.
[18] Randy J Read,et al. Recent developments in the PHENIX software for automated crystallographic structure determination. , 2004, Journal of synchrotron radiation.
[19] Sergei L. Kosakovsky Pond,et al. HyPhy: hypothesis testing using phylogenies , 2005, Bioinform..
[20] Anchi Cheng,et al. Automated molecular microscopy: the new Leginon system. , 2005, Journal of structural biology.
[21] Mathieu Rouard,et al. IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains. , 2005, Developmental and comparative immunology.
[22] R. Wyatt,et al. Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage. , 2005, Virology.
[23] Renate Kunert,et al. Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies , 2005, Science.
[24] Rodrigo Lopez,et al. Clustal W and Clustal X version 2.0 , 2007, Bioinform..
[25] J. Mascola,et al. Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs. , 2007, Vaccine.
[26] Michel C Nussenzweig,et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. , 2008, Journal of immunological methods.
[27] C. Gray,et al. Establishing a Cohort at High Risk of HIV Infection in South Africa: Challenges and Experiences of the CAPRISA 002 Acute Infection Study , 2008, PloS one.
[28] B. Korber,et al. Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing , 2008, Journal of Virology.
[29] G. Sapiro,et al. Molecular architecture of native HIV-1 gp120 trimers , 2008, Nature.
[30] Barry Honig,et al. Loop modeling: Sampling, filtering, and scoring , 2007, Proteins.
[31] Sergei L. Kosakovsky Pond,et al. A maximum likelihood method for detecting directional evolution in protein sequences and its application to influenza A virus. , 2008, Molecular biology and evolution.
[32] Xuesong Yu,et al. Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection , 2008, Journal of Virology.
[33] Jan Berka,et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire , 2009, Proceedings of the National Academy of Sciences.
[34] Richard T. Wyatt,et al. Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables , 2009, Journal of Virology.
[35] J. Baeten,et al. Breadth of Neutralizing Antibody Response to Human Immunodeficiency Virus Type 1 Is Affected by Factors Early in Infection but Does Not Influence Disease Progression , 2009, Journal of Virology.
[36] Pham Phung,et al. Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target , 2009, Science.
[37] M Radermacher,et al. DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy. , 2009, Journal of structural biology.
[38] Christopher Irving,et al. Appion: an integrated, database-driven pipeline to facilitate EM image processing. , 2009, Journal of structural biology.
[39] David C Montefiori,et al. Measuring HIV neutralization in a luciferase reporter gene assay. , 2009, Methods in molecular biology.
[40] A. Sethi,et al. The B Cell Response Is Redundant and Highly Focused on V1V2 during Early Subtype C Infection in a Zambian Seroconverter , 2010, Journal of Virology.
[41] Tongqing Zhou,et al. Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 , 2010, Science.
[42] Mario Roederer,et al. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.
[43] G. Shaw,et al. A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays. , 2010, Virology.
[44] J M Carazo,et al. A clustering approach to multireference alignment of single-particle projections in electron microscopy. , 2010, Journal of structural biology.
[45] Paramvir S. Dehal,et al. FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments , 2010, PloS one.
[46] Dennis R. Burton,et al. A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals , 2010, PLoS pathogens.
[47] L. Morris,et al. The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection , 2011, Journal of Virology.
[48] Young Do Kwon,et al. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 , 2011, Nature.
[49] Mario Roederer,et al. Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing , 2011, Science.
[50] Yan Liu,et al. A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield , 2011, Science.
[51] L. Morris,et al. Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop , 2011, Journal of Virology.
[52] M. Nei,et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. , 2011, Molecular biology and evolution.
[53] Pham Phung,et al. Broad neutralization coverage of HIV by multiple highly potent antibodies , 2011, Nature.
[54] T. Kepler,et al. Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors , 2011, Journal of Virology.
[55] L. Morris,et al. The Antibody Response against HIV-1. , 2012, Cold Spring Harbor perspectives in medicine.
[56] Guido Ferrari,et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. , 2012, The New England journal of medicine.
[57] J. Mullikin,et al. Somatic Populations of PGT135–137 HIV-1-Neutralizing Antibodies Identified by 454 Pyrosequencing and Bioinformatics , 2012, Front. Microbio..
[58] Adi Doron-Faigenboim,et al. FastML: a web server for probabilistic reconstruction of ancestral sequences , 2012, Nucleic Acids Res..
[59] Baoshan Zhang,et al. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody , 2012, Nature.
[60] J. Mascola,et al. Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies. , 2012, Immunity.
[61] B A McKinney,et al. High-throughput antibody sequencing reveals genetic evidence of global regulation of the naïve and memory repertoires that extends across individuals , 2012, Genes and Immunity.
[62] J. Binley,et al. HIV-1 Virus-Like Particles Bearing Pure Env Trimers Expose Neutralizing Epitopes but Occlude Nonneutralizing Epitopes , 2012, Journal of Virology.
[63] Gwo-Yu Chuang,et al. A Short Segment of the HIV-1 gp120 V1/V2 Region Is a Major Determinant of Resistance to V1/V2 Neutralizing Antibodies , 2012, Journal of Virology.
[64] Patrice Duroux,et al. IMGT/HIGHV-QUEST: THE IMGT® WEB PORTAL FOR IMMUNOGLOBULIN (IG) OR ANTIBODY AND T CELL RECEPTOR (TR) ANALYSIS FROM NGS HIGH THROUGHPUT AND DEEP SEQUENCING , 2012 .
[65] Tomer Hertz,et al. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env-V2 , 2012, Nature.
[66] Guillermo Sapiro,et al. Structural Mechanism of Trimeric HIV-1 Envelope Glycoprotein Activation , 2012, PLoS pathogens.
[67] Thomas B Kepler,et al. B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study , 2012, Nature Biotechnology.
[68] Adam Godzik,et al. A Blueprint for HIV Vaccine Discovery. , 2012, Cell host & microbe.
[69] James E. Crowe,et al. Human Peripheral Blood Antibodies with Long HCDR3s Are Established Primarily at Original Recombination Using a Limited Subset of Germline Genes , 2012, PloS one.
[70] Sergei L. Kosakovsky Pond,et al. Detecting Individual Sites Subject to Episodic Diversifying Selection , 2012, PLoS genetics.
[71] Q. Sattentau,et al. Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine Design. , 2012, Journal of AIDS & clinical research.
[72] John P. Moore,et al. Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9 , 2013, Proceedings of the National Academy of Sciences.
[73] Baoshan Zhang,et al. Mining the antibodyome for HIV-1–neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains , 2013, Proceedings of the National Academy of Sciences.
[74] Tongqing Zhou,et al. Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization , 2013, Science.
[75] B. Haynes,et al. HIV‐1 neutralizing antibodies: understanding nature's pathways , 2013, Immunological reviews.
[76] L. Morris,et al. Multiple Pathways of Escape from HIV Broadly Cross-Neutralizing V2-Dependent Antibodies , 2013, Journal of Virology.
[77] George Georgiou,et al. High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire , 2013, Nature Biotechnology.
[78] Baoshan Zhang,et al. Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16 , 2013, Nature Structural &Molecular Biology.
[79] John P. Moore,et al. Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer , 2013, Science.
[80] J. Mascola,et al. High throughput HIV-1 microneutralization assay , 2013 .
[81] J. Mascola,et al. Isolation of human monoclonal antibodies from peripheral blood B cells , 2013, Nature Protocols.
[82] John P. Moore,et al. Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer , 2013, Science.
[83] Chaim A. Schramm,et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus , 2013, Nature.
[84] Ryan McBride,et al. Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans , 2013, PLoS pathogens.